Seres Therapeutics, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Seres Therapeutics, Inc. (MCRB) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$14.62 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2015-11-12
- Seres Therapeutics, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2015-09-30 was -$14.62M.
- Seres Therapeutics, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2015-06-30 was -$12.55M.
- Seres Therapeutics, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-09-30 was -$4.62M.
- Seres Therapeutics, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2014-06-30 was -$3.00M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2015-09-30 | -$14.62M 10-Q · filed 2015-11-12 | -$27.18M derived: sum of 2 quarters · filed 2015-11-12 | -$35.15M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$12.55M 10-Q · filed 2015-08-10 | -$20.53M 10-Q · filed 2015-08-10 | |
| 2014-09-30 | -$4.62M 10-Q · filed 2015-11-12 | -$7.62M derived: sum of 2 quarters · filed 2015-11-12 | -$9.55M 10-Q · filed 2015-11-12 |
| 2014-06-30 | -$3.00M 10-Q · filed 2015-08-10 | -$4.92M 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |